Simvastatin is associated with decreased risk of Parkinson disease
Ann Neurol
.
2017 Feb;81(2):329-330.
doi: 10.1002/ana.24857.
Authors
Brage Brakedal
1
2
,
Kristoffer Haugarvoll
1
2
,
Charalampos Tzoulis
1
2
Affiliations
1
Department of Neurology, Haukeland University Hospital.
2
Department of Clinical Medicine, University of Bergen, Bergen, Norway.
PMID:
28019662
DOI:
10.1002/ana.24857
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Diabetes Mellitus*
Disease Models, Animal
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Parkinson Disease*
Simvastatin
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin